These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 38260)
1. Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa. Mosher DF; Schad PE J Clin Invest; 1979 Sep; 64(3):781-7. PubMed ID: 38260 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of blood coagulation factor XIIIa-mediated cross-linking between fibronectin and collagen by polyamines. Mosher DF; Schad PE; Kleinman HK J Supramol Struct; 1979; 11(2):227-35. PubMed ID: 548650 [TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus fibronectin-binding protein serves as a substrate for coagulation factor XIIIa: evidence for factor XIIIa-catalyzed covalent cross-linking to fibronectin and fibrin. Matsuka YV; Anderson ET; Milner-Fish T; Ooi P; Baker S Biochemistry; 2003 Dec; 42(49):14643-52. PubMed ID: 14661977 [TBL] [Abstract][Full Text] [Related]
4. Factor XIIIa mediated attachment of S. aureus fibronectin-binding protein A (FnbA) to fibrin: identification of Gln103 as a major cross-linking site. Severina E; Nunez L; Baker S; Matsuka YV Biochemistry; 2006 Feb; 45(6):1870-80. PubMed ID: 16460033 [TBL] [Abstract][Full Text] [Related]
5. Effects of cross-linking on clearance of circulating alpha-fibrin monomer and its complexes. Shainoff JR; Dardik BN J Lab Clin Med; 1990 Mar; 115(3):314-23. PubMed ID: 1968950 [TBL] [Abstract][Full Text] [Related]
7. Determinants of substrate specificity for factor XIII. McDonagh J; Fukue H Semin Thromb Hemost; 1996; 22(5):369-76. PubMed ID: 8989819 [TBL] [Abstract][Full Text] [Related]
8. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354 [TBL] [Abstract][Full Text] [Related]
9. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Schense JC; Hubbell JA Bioconjug Chem; 1999; 10(1):75-81. PubMed ID: 9893967 [TBL] [Abstract][Full Text] [Related]
10. The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate. Jeleńska MM; Fesüs L; Kopeć M Biochim Biophys Acta; 1980 Dec; 616(2):167-78. PubMed ID: 6111338 [TBL] [Abstract][Full Text] [Related]
11. Fibronectin (cold-insoluble globulin): role in defence. Vaheri A Schweiz Med Wochenschr; 1980 Oct; 110(40):1437-40. PubMed ID: 7025190 [TBL] [Abstract][Full Text] [Related]
12. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis. Mimuro J; Kimura S; Aoki N J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360 [TBL] [Abstract][Full Text] [Related]
13. Cross-linked alpha s gamma t-chain hybrids in plasma clots studied by 1D- and 2D electrophoresis and western blotting. Grøn B; Filion-Myklebust C; Bjørnsen S; Haidaris P; Brosstad F Thromb Haemost; 1993 Sep; 70(3):438-42. PubMed ID: 8259545 [TBL] [Abstract][Full Text] [Related]
14. Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration. Lanir N; Ciano PS; Van de Water L; McDonagh J; Dvorak AM; Dvorak HF J Immunol; 1988 Apr; 140(7):2340-9. PubMed ID: 3351302 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation. Murtaugh PA Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486 [TBL] [Abstract][Full Text] [Related]
16. Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell layers. Cross-linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments. Barry EL; Mosher DF J Biol Chem; 1989 Mar; 264(7):4179-85. PubMed ID: 2917995 [TBL] [Abstract][Full Text] [Related]
17. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin. Schwartz ML; Pizzo SV; Hill RL; McKee PA J Clin Invest; 1971 Jul; 50(7):1506-13. PubMed ID: 5090065 [TBL] [Abstract][Full Text] [Related]
18. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. Sakata Y; Aoki N J Clin Invest; 1980 Feb; 65(2):290-7. PubMed ID: 6444305 [TBL] [Abstract][Full Text] [Related]
19. Immunochemical characterization of crosslinked derivatives isolated from alpha chain oligomers formed during early stages of fibrin crosslinking. Sobel JH; Thibodeau CA; Gawinowicz Kolks MA; Canfield RE Thromb Haemost; 1988 Oct; 60(2):160-9. PubMed ID: 3217917 [TBL] [Abstract][Full Text] [Related]